Adtalem Global Education Inc. (CVSA) – What Are Researchers Saying About This Stock?

Shares of Adtalem Global Education Inc. (NYSE:CVSA) have received a consensus recommendation of “Hold” from the five research firms that are currently covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $151.67.

CVSA has been the topic of a number of research analyst reports. Wall Street Zen raised Adtalem Global Education from a “hold” rating to a “buy” rating in a report on Sunday, September 27th. Weiss Ratings raised shares of Adtalem Global Education from a “hold (c)” rating to a “hold (c+)” rating in a report on Wednesday, October 21st. BMO Capital Markets cut their price target on shares of Adtalem Global Education from $148.00 to $145.00 and set an “outperform” rating for the company in a report on Monday, October 5th. Finally, Truist Financial lowered shares of Adtalem Global Education from a “buy” rating to a “hold” rating and set a $140.00 price objective for the company. in a research report on Thursday, September 3rd.

Insider Buying and Selling

In related news, CEO Stephen W. Beard sold 4,667 shares of the firm’s stock in a transaction that occurred on Friday, October 9th. The shares were sold at an average price of $130.77, for a total transaction of $610,303.59. Following the completion of the sale, the chief executive officer directly owned 469,158 shares in the company, valued at approximately $61,351,791.66. This trade represents a 0.98% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Manjunath Gangadharan sold 1,802 shares of Adtalem Global Education stock in a transaction that occurred on Thursday, August 27th. The stock was sold at an average price of $137.18, for a total transaction of $247,198.36. Following the completion of the transaction, the chief accounting officer owned 5,083 shares in the company, valued at approximately $697,285.94. This trade represents a 26.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 13,653 shares of company stock worth $1,793,974 over the last quarter. Insiders own 2.70% of the company’s stock.

Institutional Investors Weigh In On Adtalem Global Education

An institutional investor recently raised its stake in Adtalem Global Education stock. Kendall Capital Management lifted its stake in shares of Adtalem Global Education Inc. (NYSE:CVSA) by 23.7% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 14,375 shares of the company’s stock after purchasing an additional 2,753 shares during the period. Kendall Capital Management’s holdings in Adtalem Global Education were worth $1,757,000 at the end of the most recent quarter. 98.84% of the stock is currently owned by hedge funds and other institutional investors.

Adtalem Global Education Stock Down 8.7%

Shares of CVSA stock opened at $113.35 on Friday. Adtalem Global Education has a 1 year low of $86.97 and a 1 year high of $142.13. The stock has a market cap of $3.77 billion, a PE ratio of 15.49, a price-to-earnings-growth ratio of 0.91 and a beta of 0.70. The business’s fifty day moving average is $126.87 and its 200-day moving average is $122.05. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.81 and a current ratio of 0.81.

Adtalem Global Education (NYSE:CVSA) last posted its quarterly earnings data on Thursday, October 29th. The company reported $2.19 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.29. The company had revenue of $511.53 million for the quarter. Adtalem Global Education had a return on equity of 21.79% and a net margin of 12.84%. Equities analysts expect that Adtalem Global Education will post 9.10 earnings per share for the current fiscal year.

Adtalem Global Education Company Profile

Adtalem Global Education, Inc is an education services company that provides healthcare and professional education through institutions serving students in the United States and internationally. The company focuses on preparing students for careers in healthcare, including nursing, medicine, veterinary medicine and other health-related fields.

Its portfolio has included Chamberlain University, Walden University, the American University of the Caribbean School of Medicine, Ross University School of Medicine and Ross University School of Veterinary Medicine.